ForSight Robotics, a Yokeneam, Israel-based company developing a next-generation miniature robotic system for ophthalmic surgery, raised $10m in seed funding.
The round was led by Eclipse Ventures and joined by Mithril Capital.
ForSight Robotics focuses on advancing ophthalmic surgery with robotics, advanced visualization and data analytics. The company’s platform will incorporate stereoscopic imaging technologies for surgical planning, real-time image guidance, and visualization to ensure the continuous improvement of surgical technique and exceed human surgical capabilities with more precise movements of only a few microns.
Co-Founder and CEO Daniel Glozman, Ph.D., has specialized in robotics for medical applications for over 20 years, heading R&D at Medtronic Ventor Technologies, Magenta Medical, Diagnostic Robotics, and Guide-X — which he also founded.
ForSight Co-Founder Moshe Shoham, Ph.D., is an acclaimed emeritus professor of mechanical engineering at the Technion and former head of its robotics laboratory. Besides his many academic honors, Prof. Shoham founded Mazor Robotics, a spinal robotics platform since acquired by Medtronic plc. He is an international member of the U.S. National Academy of Engineering.
Joseph Nathan, M.D., ForSight Robotics Co-Founder and Chief Business Officer, previously directed healthcare commercialization at the Technion Israel Institute of Technology, where he forged partnerships worth over $1 billion with global pharmaceutical and med-tech companies. Dr. Nathan also served as director of New Ventures for the Alfred Mann Institute at the Technion, a $100 million joint venture incubating medical startups.